UPC CFI 99/2026

Jan 12, 2026·EP2493466: NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details: Status
Case Closed
Action
Other
Category
Other Procedural
Parties: Claimants
Zentiva, k.s.
Zentiva Pharma GmbH
Zentiva France
Reps: Anja Lunze
Respondents
Sanofi Mature IP
Reps: Frédéric Chevallier
Division: Munich LD
Judges: Matthias Zigann
Tobias Pichlmaier
Alima Zana
Technology: Pharmaceutical & Medical
Language: English

Documents

Document title	Date	Public
action.publishOrderDecision.case	2026-02-23	Not public
action.phaseChange.caseClose	2026-02-03	Not public
Receipt	2026-01-12	Not public
Cover sheet	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Application document Applicant	2026-01-12	Not public